Markers of disease activity in chronic hepatitis B virus infection

Clinical and Investigative Medicine

Volumn 26, Issue 1, 2003, Pages 27-34

  Yalcin, Kendal ^a,c   Degertekin, Halil ^a   Yildiz, Fetin ^b   Celik, Yusuf ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

^c DICLE UNIVERSITY   (Turkey)

Author keywords

Alanine transaminase; Biological markers; DNA, viral; Hepatitis B antibodies; Hepatitis B e antigens; Hepatitis B surface antigens; Hepatitis B, chronic; Hepatitis, viral, human

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CELL DAMAGE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); VIRUS INFECTION; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGE FACTORS; ALANINE TRANSAMINASE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0038579634     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. World Health Organization. Global health situation and projections and estimates. Geneva: World Health Organization; 1993.
2. Karayannis P, Fowler MJ, Lok AS, Greenfield C, Monjardino J, Thomas HC. Detection of serum HBV DNA by molecular hybridization: correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985;1:99-106.
3. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8.
4. Realdi G, Alberti A, Rugge M, Bortolotti F, Rigoli AM, Tremolada F, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-9.
5. Hsu HC, Su IJ, Lai MY, Chen DS, Chang MH, Chuang SM, et al. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol 1987;5:45-50.
6. Mels GC, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, et al. Fluctuations in in viremia, amino-transferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 1994;14:175-81.
7. Degertekin H, Tuzcu A, Yalçin K. Horizontal transmission of HBV infection among students in Turkey. Public Health 2000;114:411-2.
8. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
9. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific; 1994.
10. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the 'healthy' HBsAg carrier state. Hepatology 1987;7:758-63.
11. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
12. Brunetto MR, Giarin MM, Oliveri F, Chiaberge E, Baldi M, Alfarano A, et al. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 1991;88:4180-90.
13. Thomas HC, Carman WF. Envelope and precore/core variants of hepatitis B virus. Gastroenterol Clin North Am 1994;23:499-514.
14. Laskus T, Rakela J, Nowicki MJ, Persing DH. Hepatitis B core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995;109:1618-23.
15. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV DNA and anti-HBe. Gastroenterology 1986;90:1268-73.
16. Fattovich G, Brollo L, Alberti A, Giustina G, Pontisso P, Realdi G, et al. Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. J Hepatol 1990;11:29-33.
17. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000;7:258-67.
18. Hadziyannis S, Bramou T, Alexopoulou A, Makris A. Immunopathogenesis and natural course of anti-HBe positive chronic hepatitis B. In: Hollinger FB, Lemon SM, Margolis HS, editors. Proceedings of the 1990 international symposium on viral hepatitis and liver disease, Houston, Texas, April 5-8, 1990. Baltimore: Williams & Wilkins; 1991. p. 673-6.
19. Hamasaki K, Nakata K, Nagayama Y, Ohtsuru A, Daikoku M, Taniguchi K, et al. Changes in the prevalence of HBeAg negative mutant hepatitis B virus during the course of chronic hepatits B. Hepatology 1994;20:8-14.
20. Zavaglia C, Mondazzi L, Maggi G, Iamoni G, Gelosa F, Bellati G, et al. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B. Liver 1997;17:83-7.
21. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, et al. Correlation between serum transaminase activity and virus load among patients with chronic liver disease type B. Hepatol Res 2001;21:159-68.
22. Rapicetta M, di Nardo V, Rozera C, Marinucci G, Francisci D, Sarrecchia B, et al. HBV DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy. Epidemiol Infect 1990;104:511-7.
23. Carloni G, Colloca S, Delfini C, Manzin A, Clementi M, Galibert F. Detection of HBV infectivity by spot hybridization in HBeAg-negative chronic carriers: HBV DNA in sera from asymptomatic and symptomatic subjects. J Med Virol 1987;21:15-23.
24. Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Am J Gastroenterol 1997;92:119-23.
25. Liaw YF, Chu CM, Lin DY, Sheen IS, Yang CY, Huang MJ. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carders, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Med Virol 1984;13:385-91.
26. Chu CH, Liaw YF, Sheen IS, Chen TJ. Correlation of age with the status of hepatitis B virus replication and histological changes in chronic type B hepatitis. Liver 1985;5:117-22.
27. Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo P, Capra G, et al. Hepatitis B virus unable to secrete e antigen response to interferon in chronic hepatitis B. Gastroenterology 1993;105:845-50.
28. Hadziyannis SJ, Vassilopoulos D. Hepatitis Be antigen-negative chronic hepatitis B. Hepatology 2001;34:617-24.
29. Ljunggren KK, Nordenfelt E, Kidd A. Correlation of HBeAg/anti-HBe, ALT levels and HBV DNA PCR results in HBsAg-positive patients. J Med Virol 1993;39:297-302.
30. Jardi R, Buti M, Rodriguez-Frias F, Cortina M, Esteban R, Guardia J, et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996;24:680-5.
31. Shih LN, Sheu JC, Wang JT, Huang GT, Chen JS, Sung JL, et al. Detection of hepatitis B viral DNA by polymerase chain reaction in patients with hepatitis B surface antigen. J Med Virol 1990;30:159-62.
32. Lok AS, Heathcote J, Hoofnagle J. Management of hepatitis B: 2000 - summary of a workshop [review]. Gastroenterology 2001;120:1828-53.
33. Lok AS, Mc Mahon BJ. Chronic hepatitis B. Hepatology 2001;34:1225-41.